Crinetics Pharmaceuticals, Inc. (CRNX) NASDAQ
38.41
-0.695(-1.78%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
38.41
-0.695(-1.78%)
Currency In USD
| Market Cap | 4.38B |
| Enterprise Value | 4.33B |
| P/E Ratio | -7.76 |
| PEG Ratio | 0.29 |
| Price/Sales Ratio | 741.92 |
| Price/Book Ratio | 3.64 |
| Enterprise/Revenue | 732.14 |
| Enterprise/EBITDA | -7.91 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -85.85 |
| Operating Margin | -95.34 |
| Return On Assets | -0.41 |
| Return On Equity | -0.41 |
| Revenue | 7.7M |
| Revenue/Share | 0.06 |
| Gross Profit | 2.73M |
| EBITDA | -461.25M |
| Net Income | -465.32M |
| Diluted EPS | -4.95 |
| Total Cash | 1.03B |
| Total Cash/Share | 10.93 |
| Total Debt | 48.54M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 12.32 |
| Book Value Per Share | 10.55 |
| 52-Week Change | 18.64 |
| 52-Week High | 57.99 |
| 52-Week Low | 25.83 |
| Moving Average 50 Days | 39.42 |
| Moving Average 200 Days | 40.44 |
| Average Volume | 1.07M |
| Shares Outstanding | 104.71M |
| % Held by Institutions | 118.46 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |